You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 72 No. 3, SEPTEMBER 1943 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

SULFADIAZINE ADMINISTERED ALONE AND WITH ANTIPNEUMOCOCCUS SERUM IN THE TREATMENT OF PNEUMOCOCCIC PNEUMONIA

NATHAN H. SHACKMAN, M.D.; JESSE G. M. BULLOWA, M.D.

Arch Intern Med. 1943;72(3):329-345.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Sulfadiazine (2-[paraaminobenzenesulfonamido]-pyrimidine), the pyrimidine analog of sulfapyridine, has been shown by Feinstone and his associates1 in their experiments with mice to be less toxic than either sulfapyridine or sulfathiazole. They found the drug to be readily absorbed into the blood and rapidly excreted in the urine. Higher concentrations were obtained with sulfadiazine than with equivalent doses of sulfapyridine or sulfathiazole. Long and his co-workers2 reported that sulfadiazine was less effective at equivalent concentrations than sulfathiazole in the treatment of experimental pneumococcic infections in mice. Osgood and Bullowa,3 using tissue cultures, found sulfadiazine to be only one-quarter as effective against pneumococci as sulfapyridine and sulfathiazole in equivalent concentrations.

Studies on the action of sulfadiazine in human beings have been reported by various investigators.4 With an associate we5 have previously reported on the pharmacodynamics of the drug in man. It is well absorbed from the gastrointestinal tract. . . . [Full Text PDF of this Article]


Author Affiliations

Clinical Professor of Medicine, New York University College of Medicine, and Visiting Physician, Harlem Hospital and Willard Parker Hospital NEW YORK

From the Medical Service, Harlem Hospital, Department of Hospitals, New York city and the Littauer Pneumonia Research Fund of New York University College of Medicine These studies received additional support from the Metropolitan Life Insurance Company an from Mr. Bernard M. Baruch, Mr. Bernard M. Baruch Jr., Miss Belle N. Baruch and Mrs H. Robert Samstag.


Footnotes

Littauer Fellow in Pneumonia Research, Harlem Hospital.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1943 American Medical Association. All Rights Reserved.